Black Friday Sale: Get 75% off a digital subscription
The Baltimore Sun


A bottle and pills of the diabetes drug, Avandia. The U.S. Food and Drug Administration panel voted to recommend that GlaxoSmithKline PLC's (GSK) diabetes drug, Avandia, remain on the market despite concerns that the product could raise the risk of heart attacks. (Photo by illustration Joe Raedle/Getty Images)